State Street
TMO icon

State Street’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.69B Sell
16,480,965
-58,524
-0.4% -$23.8M 0.25% 71
2025
Q1
$8.24B Buy
16,539,489
+91,461
+0.6% +$45.5M 0.34% 48
2024
Q4
$8.56B Buy
16,448,028
+129,067
+0.8% +$67.2M 0.34% 47
2024
Q3
$10.1B Buy
16,318,961
+124,996
+0.8% +$77.4M 0.41% 39
2024
Q2
$8.96B Sell
16,193,965
-389,979
-2% -$216M 0.39% 42
2024
Q1
$9.65B Buy
16,583,944
+107,060
+0.6% +$62.3M 0.43% 38
2023
Q4
$8.75B Buy
16,476,884
+835,295
+5% +$444M 0.43% 40
2023
Q3
$7.92B Sell
15,641,589
-475,367
-3% -$241M 0.44% 37
2023
Q2
$8.41B Buy
16,116,956
+55,458
+0.3% +$29M 0.44% 36
2023
Q1
$9.26B Sell
16,061,498
-223,763
-1% -$129M 0.52% 32
2022
Q4
$8.97B Buy
16,285,261
+126,385
+0.8% +$69.6M 0.53% 31
2022
Q3
$8.2B Buy
16,158,876
+135,437
+0.8% +$68.7M 0.52% 31
2022
Q2
$8.71B Sell
16,023,439
-194,196
-1% -$106M 0.52% 31
2022
Q1
$9.58B Sell
16,217,635
-5,538
-0% -$3.27M 0.47% 33
2021
Q4
$10.8B Buy
16,223,173
+529,712
+3% +$354M 0.51% 29
2021
Q3
$8.97B Buy
15,693,461
+139,803
+0.9% +$79.9M 0.47% 33
2021
Q2
$7.85B Buy
15,553,658
+318,930
+2% +$161M 0.41% 46
2021
Q1
$6.96B Sell
15,234,728
-544,269
-3% -$249M 0.4% 50
2020
Q4
$7.35B Sell
15,778,997
-515,227
-3% -$240M 0.45% 46
2020
Q3
$7.2B Sell
16,294,224
-268,082
-2% -$118M 0.49% 40
2020
Q2
$6B Buy
16,562,306
+58,542
+0.4% +$21.2M 0.44% 45
2020
Q1
$4.68B Buy
16,503,764
+165,895
+1% +$47.1M 0.41% 51
2019
Q4
$5.31B Buy
16,337,869
+224,799
+1% +$73.1M 0.36% 56
2019
Q3
$4.7B Sell
16,113,070
-125,719
-0.8% -$36.6M 0.35% 57
2019
Q2
$4.77B Sell
16,238,789
-168,307
-1% -$49.5M 0.36% 55
2019
Q1
$4.49B Buy
16,407,096
+775,253
+5% +$212M 0.35% 59
2018
Q4
$3.5B Buy
15,631,843
+96,199
+0.6% +$21.5M 0.32% 64
2018
Q3
$3.79B Buy
15,535,644
+758,451
+5% +$185M 0.29% 75
2018
Q2
$3.06B Sell
14,777,193
-305,305
-2% -$63.2M 0.26% 79
2018
Q1
$3.11B Sell
15,082,498
-862,415
-5% -$178M 0.26% 76
2017
Q4
$3.03B Buy
15,944,913
+157,424
+1% +$29.9M 0.24% 83
2017
Q3
$2.99B Sell
15,787,489
-176,208
-1% -$33.3M 0.26% 82
2017
Q2
$2.79B Sell
15,963,697
-122,257
-0.8% -$21.3M 0.25% 83
2017
Q1
$2.47B Buy
16,085,954
+164,367
+1% +$25.2M 0.22% 94
2016
Q4
$2.25B Buy
15,921,587
+586,414
+4% +$82.7M 0.21% 99
2016
Q3
$2.44B Buy
15,335,173
+324,006
+2% +$51.5M 0.25% 86
2016
Q2
$2.22B Sell
15,011,167
-114,377
-0.8% -$16.9M 0.24% 89
2016
Q1
$2.14B Sell
15,125,544
-255,388
-2% -$36.2M 0.23% 93
2015
Q4
$2.18B Buy
15,380,932
+59,041
+0.4% +$8.37M 0.24% 84
2015
Q3
$1.87B Sell
15,321,891
-129,178
-0.8% -$15.8M 0.22% 96
2015
Q2
$2B Sell
15,451,069
-593,779
-4% -$77M 0.21% 98
2015
Q1
$2.16B Sell
16,044,848
-912,606
-5% -$123M 0.22% 95
2014
Q4
$2.12B Buy
16,957,454
+980,025
+6% +$123M 0.21% 102
2014
Q3
$1.94B Buy
15,977,429
+316,177
+2% +$38.5M 0.21% 102
2014
Q2
$1.85B Buy
15,661,252
+426,870
+3% +$50.4M 0.2% 113
2014
Q1
$1.83B Buy
15,234,382
+620,417
+4% +$74.6M 0.21% 101
2013
Q4
$1.63B Buy
14,613,965
+313,710
+2% +$34.9M 0.18% 116
2013
Q3
$1.32B Sell
14,300,255
-725
-0% -$66.8K 0.16% 135
2013
Q2
$1.21B Buy
+14,300,980
New +$1.21B 0.16% 134